Swindells S, Andrade-Villanueva JF, Richmond GJ, et al. Long-acting cabotegravir + rilpivirine as maintenance therapy: ATLAS week 48 results. CROI 2019, abstract 139.
Remdesivir bij COVID-19: eindresultaten van de WHO Solidarity-studie
aug 2022 | Pneumonie, Virale infecties